RetinalGenix Technologies Inc.
Medical device company · Petaluma, California, United States · OTC: RTGN
RetinalGenix Technologies Inc. is a medical device company headquartered in Petaluma, California, United States. Its earliest recorded incorporation is in 2017. Its shares trade on OTC under the ticker RTGN. It has reported private securities offerings to the US SEC, most recently $653,089 sold in a notice filed in 2025.
RetinalGenix Technologies at a glance
What does RetinalGenix Technologies do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $653,089 sold (2025).
Frequently asked questions about RetinalGenix Technologies
Where is RetinalGenix Technologies headquartered?
RetinalGenix Technologies Inc. is headquartered in Petaluma, California, United States.
What does RetinalGenix Technologies do?
RetinalGenix Technologies Inc. is a medical device company. Its SEC industry classification is Surgical & Medical Instruments & Apparatus.
Is RetinalGenix Technologies a public company?
Yes. RetinalGenix Technologies Inc. trades on OTC under the ticker RTGN.
When was RetinalGenix Technologies founded?
The earliest incorporation on record for RetinalGenix Technologies Inc. is in 2017, according to public company registers.
Similar companies
- GLAUKOS CorpAliso Viejo, California, United States
- Mobia Medical, Inc.Austin, Texas, United States
- Pulse Biosciences, Inc.Hayward, California, United States
- Artivion, Inc.Kennesaw, Georgia, United States
- PAVmed Inc.New York City, New York, United States
- Medtronic IncMinneapolis, Minnesota, United States
- Sintx Technologies, Inc.Salt Lake City, Utah, United States
- Axogen, Inc.Alachua, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences